Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc interventions image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Intv, 2009; 2:861-870, doi:10.1016/j.jcin.2009.05.024
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wykrzykowska, J. J.
Right arrow Articles by Windecker, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wykrzykowska, J. J.
Right arrow Articles by Windecker, S.

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer

The LEADERS Trial Substudy

Joanna J. Wykrzykowska, MD*, Patrick W. Serruys, MD, PhD*,*, Yoshinobu Onuma, MD*, Ton de Vries, MA{dagger}, Gerrit-Anne van Es, PhD{dagger}, Pawel Buszman, MD{ddagger}, Axel Linke, MD§, Thomas Ischinger, MD||, Volker Klauss, MD, Roberto Corti, MD#, Franz Eberli, MD, PhD#,¶¶, William Wijns, MD**, Marie-Claude Morice, MD{dagger}{dagger}, Carlo di Mario, MD, PhD{ddagger}{ddagger}, Robert Jan van Geuns, MD, PhD*, Peter Juni, MD, PhD§§, Stephan Windecker, MD, PhD||||

* Department of Interventional Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands
{dagger} Cardialysis, Rotterdam, the Netherlands
{ddagger} Medical University of Silesia, Katowice, Poland
§ Herzzentrum Leipzig, Leipzig, Germany
|| Department of Cardiology, Hospital Bogenhausen, Munich, Germany
Department of Cardiology, University Hospital Munich (Innenstadt), Munich, Germany
# Department of Cardiology, University Hospital, Zurich, Switzerland
** Department of Cardiology, Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium
{dagger}{dagger} Institut Cardiovasculaire, Paris-Sud, France
{ddagger}{ddagger} Department of Cardiology, Royal Brompton Hospital, London, United Kingdom
§§ Clinical Trials Unit Bern, Bern University Hospital, Bern, Switzerland
|||| Department of Cardiology, Bern University Hospital, Bern, Switzerland
¶¶ Triemlispital, Zurich, Switzerland


Figure 1
View larger version (37K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Structure of Biolimus and Scanning Electron Micrograph of the Biolimus Biodegradable Polymer Stent

 

Figure 2
View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Study Flow Chart

 

Figure 3
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Kaplan-Meier Curves for Overall MACE Rate at 1 Year

Kaplan-Meier curves for overall major adverse cardiac events (MACE) rate at 1 year. (A) Small vessels; (B) large vessels; (C) mixed vessels; (D) all vessels.

 

Figure 4
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Kaplan-Meier Curves for TLR Rates at 1 Year

Kaplan-Meier curves for target lesion revascularization (TLR) rates at 1 year. (A) Small vessels; (B) large vessels; (C) mixed vessels (p = 0.05); (D) all vessels.

 




Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link